Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fraia Melchionda

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|May 31, 2014
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemiaAntonino Maria Spartà, Daniela Bressanin, Francesca Chiarini, et al.
Urologic Oncology|September 26, 2018
Malignant testicular germ cell tumors in children and adolescents: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) protocolMonica Terenziani, Maria D De Pasquale, Gianni Bisogno, et al.
Pediatric Blood & Cancer|June 10, 2017
Factors possibly affecting prognosis in children with Wilms' tumor diagnosed before 24 months of age: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Wilms Tumor Working GroupPaolo D'Angelo, Andrea Di Cataldo, Monica Terenziani, et al.
Pediatric Blood & Cancer|March 8, 2021
Proton therapy: A therapeutic opportunity for aggressive pediatric meningiomaBarbara Rombi, Alessandro Ruggi, Iacopo Sardi, et al.
Oncotarget|November 24, 2015
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κBFrancesca Buontempo, Ester Orsini, Annalisa Lonetti, et al.
Oncotarget|December 17, 2013
MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemiaAnnalisa Astolfi, Francesca Vendemini, Milena Urbini, et al.
Oncotarget|September 17, 2014
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeuticsCecilia Evangelisti, Camilla Evangelisti, Gabriella Teti, et al.
European Journal of Haematology|October 17, 2017
A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndromeDaniele Zama, Pietro Gasperini, Massimo Berger, et al.
Cancers|December 11, 2025
Risk Stratification for Cardiotoxicity in Childhood Cancer Survivors: State-of-the-Art Review and a Novel Two-Step ApproachFiorentina Guida, Marianna Fabi, Anna Balducci, et al.
International Journal of Molecular Sciences|February 25, 2023
Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK)Michele Fiore, Alberto Taddia, Valentina Indio, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|May 31, 2014
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemiaAntonino Maria Spartà, Daniela Bressanin, Francesca Chiarini, et al.
Urologic Oncology|September 26, 2018
Malignant testicular germ cell tumors in children and adolescents: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) protocolMonica Terenziani, Maria D De Pasquale, Gianni Bisogno, et al.
Pediatric Blood & Cancer|June 10, 2017
Factors possibly affecting prognosis in children with Wilms' tumor diagnosed before 24 months of age: A report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Wilms Tumor Working GroupPaolo D'Angelo, Andrea Di Cataldo, Monica Terenziani, et al.
Pediatric Blood & Cancer|March 8, 2021
Proton therapy: A therapeutic opportunity for aggressive pediatric meningiomaBarbara Rombi, Alessandro Ruggi, Iacopo Sardi, et al.
Oncotarget|November 24, 2015
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κBFrancesca Buontempo, Ester Orsini, Annalisa Lonetti, et al.
Oncotarget|December 17, 2013
MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemiaAnnalisa Astolfi, Francesca Vendemini, Milena Urbini, et al.
Oncotarget|September 17, 2014
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeuticsCecilia Evangelisti, Camilla Evangelisti, Gabriella Teti, et al.
European Journal of Haematology|October 17, 2017
A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndromeDaniele Zama, Pietro Gasperini, Massimo Berger, et al.
Cancers|December 11, 2025
Risk Stratification for Cardiotoxicity in Childhood Cancer Survivors: State-of-the-Art Review and a Novel Two-Step ApproachFiorentina Guida, Marianna Fabi, Anna Balducci, et al.
International Journal of Molecular Sciences|February 25, 2023
Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK)Michele Fiore, Alberto Taddia, Valentina Indio, et al.
Pageof 5